Shandong Branden Med.Device Co.,Ltd
11
0
0
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.1%
1 terminated/withdrawn out of 11 trials
50.0%
-36.5% vs industry average
27%
3 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications
Role: lead
Clinical Study on Disposable Sterile Urinary Catheter
Role: lead
A Study to Evaluate the Safety and Efficacy of Oral Contrast Agent for Sonography
Role: lead
Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC
Role: lead
Application of Intracavity Electrocardiogram Positioning Technique in PICC
Role: lead
Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System
Role: lead
Research on the Localization Accuracy of PICC Guided by EDUG in Real World
Role: lead
CathiportTM Clinical Efficacy and Safety Evaluation
Role: lead
Cordimax China Post Market Surveillance
Role: lead
Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter (VasoguardTM) in the Treatment of Small Coronary Vessel Stenosis With a Common Coronary Balloon Catheter (Maverick2)
Role: lead
Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter
Role: lead
All 11 trials loaded